Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

Ahead of this weekend's Super Bowl, some good news for the athletes: NFL players are largely avoiding opioid-based pain ...

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

Ajwain, or carom seeds, offers multiple health benefits such as improved digestion, reduced blood pressure, better ...

We welcome O’Ryan and colleagues’ introspective tone and call for a “global conversation” on academia’s role in healthcare.1 Their article resonates with our thoughts and experiences in pain ...

Discover the real causes behind migraines, expert-backed treatment options, and effective strategies to prevent and manage migraine attacks.

Isolated stretching is a highly effective way to improve flexibility in specific muscle groups. By focusing on a single ...

Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful chemotherapy-induced peripheral neuropathy, researchers found.

Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Futura Medical plc (LON:FUM – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 33.44 ($0.42) and traded ...